Humana Inc. $HUM Shares Sold by Russell Investments Group Ltd.

Key Points

• Russell Investments trimmed its Humana stake by 9.9% in Q3, selling 39,543 shares and finishing the quarter with 358,000 shares (~0.30% of the company) valued at about $93.08 million.
• Several large institutions materially increased positions—Massachusetts Financial Services added roughly 2.55M shares (up 273.2%) to hold 3.49M shares ($907.5M), while Norges Bank, BNY Mellon and others also built significant stakes, leaving institutional ownership at 92.38%.
• Wall Street has trimmed targets recently and the consensus rating is a "Hold" with an average price target of $225.48, indicating tempered analyst expectations.

Russell Investments Group Ltd. reduced its stake in Humana Inc. (NYSE:HUM - Free Report) by 9.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 358,000 shares of the insurance provider's stock after selling 39,543 shares during the period. Russell Investments Group Ltd. owned approximately 0.30% of Humana worth $93,077,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of HUM. Massachusetts Financial Services Co. MA increased its position in shares of Humana by 273.2% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,488,261 shares of the insurance provider's stock valued at $907,541,000 after acquiring an additional 2,553,509 shares during the last quarter. Norges Bank acquired a new position in shares of Humana in the 2nd quarter worth approximately $397,079,000. Bank of New York Mellon Corp boosted its position in shares of Humana by 161.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider's stock worth $446,911,000 after purchasing an additional 1,060,767 shares during the period. Dodge & Cox increased its holdings in Humana by 5.6% in the 2nd quarter. Dodge & Cox now owns 11,352,920 shares of the insurance provider's stock valued at $2,775,562,000 after purchasing an additional 597,705 shares during the last quarter. Finally, Neuberger Berman Group LLC increased its holdings in Humana by 2,855.5% in the 3rd quarter. Neuberger Berman Group LLC now owns 530,775 shares of the insurance provider's stock valued at $138,092,000 after purchasing an additional 512,816 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on HUM. Morgan Stanley set a $146.00 price target on Humana in a research note on Thursday, February 12th. Raymond James Financial dropped their price objective on Humana from $340.00 to $230.00 and set an "outperform" rating for the company in a research note on Friday, February 13th. TD Cowen cut their price objective on Humana from $260.00 to $173.00 and set a "hold" rating on the stock in a report on Friday, February 13th. Truist Financial decreased their target price on Humana from $285.00 to $200.00 and set a "hold" rating on the stock in a research note on Tuesday, February 17th. Finally, Jefferies Financial Group dropped their target price on Humana from $310.00 to $235.00 and set a "buy" rating for the company in a research report on Thursday, February 12th. Seven analysts have rated the stock with a Buy rating, sixteen have issued a Hold rating and three have given a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $225.48.

Insider Activity

In related news, insider Sanjay K. Shetty acquired 810 shares of the firm's stock in a transaction dated Monday, February 23rd. The stock was acquired at an average price of $185.21 per share, for a total transaction of $150,020.10. Following the purchase, the insider owned 11,657 shares of the company's stock, valued at $2,158,992.97. This represents a 7.47% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.37% of the company's stock.

Humana Stock Performance

NYSE:HUM opened at $178.25 on Tuesday. Humana Inc. has a 52 week low of $169.61 and a 52 week high of $315.35. The company has a fifty day simple moving average of $220.15 and a two-hundred day simple moving average of $251.18. The company has a quick ratio of 2.00, a current ratio of 2.00 and a debt-to-equity ratio of 0.70. The company has a market cap of $21.50 billion, a price-to-earnings ratio of 18.15, a price-to-earnings-growth ratio of 1.93 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.01) by $0.05. The business had revenue of $32.64 billion for the quarter, compared to analysts' expectations of $32.08 billion. Humana had a return on equity of 11.43% and a net margin of 0.92%.The company's revenue for the quarter was up 11.3% compared to the same quarter last year. During the same period last year, the firm earned ($2.16) earnings per share. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, equities analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 27th. This represents a $3.54 dividend on an annualized basis and a yield of 2.0%. Humana's dividend payout ratio (DPR) is currently 36.05%.

Humana Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.